Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Worth noting:

re Max Calao, Chief Commercial Officer:

He's the guy playing a big role in making the launch of Lupkynis happen.

Appointed a year ago, he has decades of experience launching drugs, including 20 years at Amgen and a lengthy stint at Alexion.

Max recently stated that Lupkynis is his 13th drug launch, and 4th transformative drug in a rare disease.

He also stated this is the fastest drug launch he's ever witnessed, which is remarkable considering it's occurring during the Covid pandemic.

In just 4 weeks Aurinia has met with payers representing 190 million Americans, which is 75% of the nation's insured lives.

re Peter Greenleaf on being well capitalized for the launch:

Peter cited this as a big advantage over other companies trying to accomplish a launch with only $100M or so, as they have to make decisions based on trying to stretch their cash, which compromises their ability to make the best decisions.

Aurinia has the luxury of not needing any cash for 2 years without any revenues! A sizeable plus.

AUPH is $10 if you strip out the cash. When you consider everything they've accomplished that price seems absurd, almost unbelievable.

My 2 cents, all imo

Good luck to all